Courses

Novel Therapeutics in the Treatment and Management of Multiple Myeloma at ASH 2017

Novel Therapeutics in the Treatment and Management of Multiple Myeloma at ASH 2017

This CME/CNE program will discuss recent advances in the treatment and management of multiple myeloma (MM) as presented at the American Society of Hematology 59th Annual Meeting & Exposition in Atlanta, Georgia. The expert faculty panel will provide learners with a scientific update regarding kidney toxicity, fractures, and other skeletal related events as they relate to MM patient care. Recent ...
View Course
Clinical Updates on Disease Modifying Therapies to Improve Outcomes for Patients with Multiple Sclerosis

Clinical Updates on Disease Modifying Therapies to Improve Outcomes for Patients with Multiple Sclerosis

This educational activity will feature content presented at the MS Paris 2017 7th Joint ECTRIMS-ACTRIMS Meeting in Paris, France. Four expert faculty will examine recent prognosis and diagnostic strategies of multiple sclerosis. An analysis of clinical trial data of current and emerging disease modifying therapies as presented at the Joint ACTRIMS-ECTRIMS meeting will be discussed. The faculty will also review ...
View Course
Best Practices to Apply JAK Inhibitors for the Management of Patients With Polycythemia Vera

Best Practices to Apply JAK Inhibitors for the Management of Patients With Polycythemia Vera

This CE program will highlight recent scientific advances in the treatment and management of patients with polycythemia vera (PV) presented at the American Society of Hematology 59th Annual Meeting & Exposition in Atlanta, Georgia. The three expert faculty will review the science and diagnostic criteria of PV, focusing on the treatment of the resistant/intolerant patient population. Recent clinical trial data, ...
View Course
Clinical Trial Update: Therapeutic Strategies to Delay Disease Progression

Clinical Trial Update: Therapeutic Strategies to Delay Disease Progression

In this module of a Four-Part Expert Interview Series, Dr. Marc E. Agronin, along with Dr. Richard S. Isaacson, course chair, will evaluate available therapeutic options for Alzheimer’s disease (AD) patient. The faculty will highlight the evolution of failed and existing therapies in AD, and their impact on current clinical care, emphasizing strategies for delaying disease progression in the modern ...
View Course
Early Diagnosis and Disease Monitoring: Pathology and Biomarkers

Early Diagnosis and Disease Monitoring: Pathology and Biomarkers

In this module of a Four-Part Expert Interview Series, Dr. James E. Galvin, along with Dr. Richard S. Isaacson, course chair, will relay optimal strategies for early diagnosis of Alzheimer’s disease (AD). Signs and symptoms for the mild, moderate and severe forms of AD will be analyzed, as well as modifiable and non-modifiable risk factors. The faculty will also review ...
View Course
Non-Pharmacological Approaches to Managing Patients With Alzheimer’s Disease

Non-Pharmacological Approaches to Managing Patients With Alzheimer’s Disease

In this module of a Four-Part Expert Interview Series, Max Lugavere, along with Dr. Richard S. Isaacson, course chair, will explore non-pharmacological approaches to managing patients with Alzheimer’s disease (AD). Multi-modal intervention factors, including nutrition exercise, sleep hygiene and continued education, among others, will be reviewed, and best practices relayed. The faculty will also highlight recent clinical trial data regarding ...
View Course